Literature DB >> 31073365

Beta-Catenin Mutation with Complex Chromosomal Changes in Desmoid Tumor of the Scalp: A Case Report.

Gary Liu1,2, Howard L Weiner3, William C Pederson1, Lesley Davies1, Edward P Buchanan1.   

Abstract

Gain-of-function mutations in the beta-catenin gene ( CTNNB1 ) drive genomic instability within different cancers. However, it is unclear whether alterations in beta-catenin signaling can still lead to chromosomal rearrangements in neoplasms without metastatic potential. Here, we report a unique case, whereby a desmoid tumor of the scalp contains a missense mutation in CTNNB1 . This mutation is located at the T41 phosphorylation site-previously reported to be necessary for proper beta-catenin degradation. Online database analysis then revealed that our mutation is likely causative of many different cancers and also absent in the healthy public. Karyotyping of the desmoid tumor cells then showed complex chromosomal changes in 16 out of 20 cells examined. To treat this patient, we surgically removed both the neoplasm and underlying calvarium and then successfully reconstructed the skull and scalp. Taken together, our data suggest that increased beta-catenin signaling can lead to genomic instability in the absence of metastatic potential.

Entities:  

Keywords:  CTNNB1; Desmoid Tumor; Wnt; benign cancer

Year:  2018        PMID: 31073365      PMCID: PMC6506329          DOI: 10.1055/s-0038-1676078

Source DB:  PubMed          Journal:  Craniomaxillofac Trauma Reconstr        ISSN: 1943-3875


  13 in total

1.  Phosphorylation of beta-catenin at S33, S37, or T41 can occur in the absence of phosphorylation at T45 in colon cancer cells.

Authors:  Zhenghe Wang; Bert Vogelstein; Kenneth W Kinzler
Journal:  Cancer Res       Date:  2003-09-01       Impact factor: 12.701

2.  Quantitative analysis of protein phosphorylation on a system-wide scale by mass spectrometry-based proteomics.

Authors:  Bernd Bodenmiller; Ruedi Aebersold
Journal:  Methods Enzymol       Date:  2010-03-01       Impact factor: 1.600

3.  Clonal chromosomal abnormalities in desmoid tumors. Implications for histopathogenesis.

Authors:  J A Bridge; C Sreekantaiah; B Mouron; J R Neff; A A Sandberg; S R Wolman
Journal:  Cancer       Date:  1992-01-15       Impact factor: 6.860

Review 4.  Two genetic hits (more or less) to cancer.

Authors:  A G Knudson
Journal:  Nat Rev Cancer       Date:  2001-11       Impact factor: 60.716

Review 5.  Frequently mutated genes/pathways and genomic instability as prevention targets in liver cancer.

Authors:  Chinthalapally V Rao; Adam S Asch; Hiroshi Y Yamada
Journal:  Carcinogenesis       Date:  2016-11-12       Impact factor: 4.944

6.  Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism.

Authors:  Chunming Liu; Yiming Li; Mikhail Semenov; Chun Han; Gyeong Hun Baeg; Yi Tan; Zhuohua Zhang; Xinhua Lin; Xi He
Journal:  Cell       Date:  2002-03-22       Impact factor: 41.582

7.  CTNNB1 mutation analysis is a useful tool for the diagnosis of desmoid tumors: a study of 260 desmoid tumors and 191 potential morphologic mimics.

Authors:  Sophie Le Guellec; Isabelle Soubeyran; Philippe Rochaix; Thomas Filleron; Agnès Neuville; Isabelle Hostein; Jean-Michel Coindre
Journal:  Mod Pathol       Date:  2012-07-06       Impact factor: 7.842

8.  β-Catenin induces T-cell transformation by promoting genomic instability.

Authors:  Marei Dose; Akinola Olumide Emmanuel; Julie Chaumeil; Jiangwen Zhang; Tianjiao Sun; Kristine Germar; Katayoun Aghajani; Elizabeth M Davis; Shilpa Keerthivasan; Andrea L Bredemeyer; Barry P Sleckman; Steven T Rosen; Jane A Skok; Michelle M Le Beau; Katia Georgopoulos; Fotini Gounari
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-26       Impact factor: 11.205

9.  Analysis of protein-coding genetic variation in 60,706 humans.

Authors:  Monkol Lek; Konrad J Karczewski; Eric V Minikel; Kaitlin E Samocha; Eric Banks; Timothy Fennell; Anne H O'Donnell-Luria; James S Ware; Andrew J Hill; Beryl B Cummings; Taru Tukiainen; Daniel P Birnbaum; Jack A Kosmicki; Laramie E Duncan; Karol Estrada; Fengmei Zhao; James Zou; Emma Pierce-Hoffman; Joanne Berghout; David N Cooper; Nicole Deflaux; Mark DePristo; Ron Do; Jason Flannick; Menachem Fromer; Laura Gauthier; Jackie Goldstein; Namrata Gupta; Daniel Howrigan; Adam Kiezun; Mitja I Kurki; Ami Levy Moonshine; Pradeep Natarajan; Lorena Orozco; Gina M Peloso; Ryan Poplin; Manuel A Rivas; Valentin Ruano-Rubio; Samuel A Rose; Douglas M Ruderfer; Khalid Shakir; Peter D Stenson; Christine Stevens; Brett P Thomas; Grace Tiao; Maria T Tusie-Luna; Ben Weisburd; Hong-Hee Won; Dongmei Yu; David M Altshuler; Diego Ardissino; Michael Boehnke; John Danesh; Stacey Donnelly; Roberto Elosua; Jose C Florez; Stacey B Gabriel; Gad Getz; Stephen J Glatt; Christina M Hultman; Sekar Kathiresan; Markku Laakso; Steven McCarroll; Mark I McCarthy; Dermot McGovern; Ruth McPherson; Benjamin M Neale; Aarno Palotie; Shaun M Purcell; Danish Saleheen; Jeremiah M Scharf; Pamela Sklar; Patrick F Sullivan; Jaakko Tuomilehto; Ming T Tsuang; Hugh C Watkins; James G Wilson; Mark J Daly; Daniel G MacArthur
Journal:  Nature       Date:  2016-08-18       Impact factor: 49.962

Review 10.  Wnt signaling in cancer.

Authors:  T Zhan; N Rindtorff; M Boutros
Journal:  Oncogene       Date:  2016-09-12       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.